Latest It Compliance News

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.

Raptis Group Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant share placement and entitlement offer, signaling a pivotal moment for the company’s capital structure.

Ainsworth Game Technology's Independent Board Committee reaffirms its recommendation for shareholders to support the proposed Scheme, responding to recent media commentary from a major shareholder.

Universal Biosensors reports solid growth in its wine testing segment and outlines plans for a capital raise alongside the upcoming AQUASCOUT water testing device launch.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.

Black Rock Mining has had the default notice on its Tanzanian Special Mining Licence lifted, removing a key regulatory hurdle for its flagship Mahenge Graphite Project and paving the way for resumption of operations and trading.

Cleo Diagnostics has completed alpha testing of its ovarian cancer pre-surgical triage assay kits, confirming robust performance and differentiation between benign and malignant disease. The company now moves forward to assay optimisation and manufacturing scale-up, edging closer to FDA submission and commercial launch.

Envirosuite Limited has entered a binding Scheme Implementation Deed with UK-based Ideagen Limited, agreeing to a full acquisition at a significant premium. The transaction values Envirosuite at approximately A$132.2 million and awaits shareholder and regulatory approvals.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.

Euro Manganese has appointed Martina Blahova as its permanent CEO, cementing leadership continuity as the company advances its strategic Chvaletice Manganese Project in Europe.

European Lithium Ltd has released compelling assay results from historical deep diamond drilling at its Tanbreez Rare Earth Project in Greenland, confirming high-grade rare earth oxides and significant gallium concentrations that support potential resource expansion.